the yes/no indicator that asks whether the participant had used benzodiazepines, which includes misuse of anxiety medications, such as diazepam (Valium), lorazepam (Ativan), clonazepam (Klonopin), chlordiazepoxide (Librium), oxazepam (Serepax), and alprazolam (Xanax) as part of the Timeline Followback Method assessment, a calendar-based measure for assessing self-reported retrospective daily estimates of alcohol, tobacco and/or illicit substance use.